SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1
Document Type: EX-4.1
Date Filed: 2026-02-12
Accession Number: 0001493152-26-006407
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226006407/ex4-1.htm

Chunk 0 of 5
Word Count: 1350
Character Count: 7956

Document Content:

Exhibit

THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT
EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING [—] [—], 2026 (THE “EFFECTIVE DATE”),
WHICH IS THE COMMENCEMENT DATE OF SALES IN THE OFFERING (AS DEFINED BELOW) TO ANYONE OTHER THAN (I) THE BENCHMARK COMPANY, LLC, OR AN
UNDERWRITER OR SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) THE BONA FIDE OFFICERS OR PARTNERS, REGISTERED PERSONS OR AFFILIATES
OF BENCHMARK COMPANY, LLC OR ANY SUCH AN UNDERWRITER OR SELECTED DEALER.

THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [—] [—], 2026. VOID AFTER 5:00 P.M., EASTERN TIME, [—] [—], 2031.

BIOVENTRIX,
INC.

FORM
OF REPRESENTATIVE’S WARRANT

For
the Purchase of [—] Shares of Common Stock

1. Purchase
Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of The Benchmark Company, LLC (“Benchmark”),
as registered owner of this Purchase Warrant (Benchmark or its assigns, the “Holder”), to BioVentrix, Inc., a Delaware
corporation (the “Company”), Holder is entitled, at any time or from time to time beginning [—] [—], 2026
(the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [—] [—], 2031 (the “Expiration
Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [—] shares (the “Warrant
Shares”), of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), subject
to adjustment as provided in Section 6 hereof. If the Expiration Date is not a business day, then this Purchase Warrant may be exercised
on the next succeeding business day in accordance with the terms herein. During the period commencing on the Commencement Date and ending
on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. The Exercise Price of this
Purchase Warrant is initially $[●] per share of Common Stock; provided, however, that upon the occurrence of any of the events
specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per share and the number of
Warrant Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall
mean the initial exercise price or the adjusted exercise price, depending on the context. The term “business day” shall mean
a day other than a Saturday, Sunday or any other day which is a federal legal holiday in the United States or any day on which the Federal
Reserve Bank of New York is authorized or required by law or other governmental action to close, provided that the Federal Reserve Bank
of New York shall not be deemed to be authorized or obligated to be closed due to a “shelter in place,” “non-essential
employee” or similar closure of physical location at the direction of any governmental authority if the bank’s electronic
funds transfer systems (including for wire transfers) are open for use by customers on such day.

2. Exercise.

2.1 Exercise
Form. In order to exercise this Purchase Warrant, the notice of exercise form attached hereto as Exhibit A (the “Notice
of Exercise”) must be duly executed and completed and delivered to the Company, together with this Purchase Warrant and, unless
exercised pursuant to Section 2.2 hereof, payment of the Exercise Price for the Warrant Shares being purchased payable in cash by wire
transfer of immediately available funds to an account designated by the Company or by certified check or official bank check. No ink
original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any
Notice of Exercise be required. If the Purchase Warrant is not exercised at or before 5:00 p.m., Eastern time, on the Expiration Date,
this Purchase Warrant shall become and be void without further force or effect, and all rights represented hereby shall cease and expire.
Each exercise hereof shall be irrevocable.

2.2 Cashless
Exercise. In lieu of exercising this Purchase Warrant by payment of cash or check payable to the order of the Company pursuant to
Section 2.1 above, Holder may elect to receive the number of Warrant Shares equal to the value of this Purchase Warrant (or the portion
thereof being exercised), by surrender of this Purchase Warrant to the Company, together with the exercise form attached hereto, in which
event the Company will issue to Holder a number of Warrant Shares in accordance with the following formula:

Where,

X=	The
number of Warrant Shares to be issued to Holder;

Y=	The
number of Warrant Shares that would be issuable upon exercise of this Purchase Warrant in accordance with the terms of this Purchase
Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

applicable, the “Fair Market Value” of a share of Common Stock determined as follows: (i) the VWAP on the Trading Day
immediately preceding the date of the applicable exercise form if such exercise form is (1) both executed and delivered pursuant
to Section 2.2 hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2.2 hereof on a Trading
Day prior to the opening of “regular trading hours” (as defined in Rule 600(b)(68) of Regulation NMS promulgated under
the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately
preceding the date of the applicable Exercise Form or (z) the Bid Price of the shares of Common Stock on the principal Trading Market
as reported by Bloomberg L.P. as of the time of the Holder’s execution of the applicable Exercise Form if such Exercise Form
is executed during “regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of “regular trading hours” on a Trading Day) pursuant to Section 2.2 hereof, which
Bid Price shall be shown on supporting documents provided by the Holder to the Company within two Trading Days of delivery of the
exercise form, or (iii) the VWAP on the date of the applicable exercise form if the date of such exercise form is a Trading Day and
such exercise form is both executed and delivered pursuant to Section 2.2 hereof after the close of “regular trading hours”
on such Trading Day; and

B=	The
Exercise Price.

“Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the shares of Common Stock for the time in question (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day
from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the shares of Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the
Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the shares of Common Stock are then reported
in the “Pink Sheets” published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions
of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market
value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable
to the Company, which determination shall be final, binding and conclusive absent fraud or manifest error and the fees and expenses of
which shall be paid by the Company.